Articles by Disease (High Pressure Neurological Syndrome)

Induction of Myocardial Fibrosis and Hypertrophy by Natriuretic Peptides

Journal: Vascular Disease Prevention (Discontinued)
Volume: 1
Page: 175-184
Author(s): Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard

Lifestyle Changes and Pharmacological Risk Factor Modification for Effective Vascular Disease Prevention

Journal: Vascular Disease Prevention (Discontinued)
Volume: 1
Page: 219-223
Author(s): Debabrata Mukherjee

The Clinical Neuroscience of Post Stroke Depression

Journal: Current Neuropharmacology
Volume: 2
Page: 353-362
Author(s): Ebrahim Haroon and Anand Kumar

The Clinical Relevance of Advanced Glycation Endproducts (AGE) and Recent Developments in Pharmaceutics to Reduce AGE Accumulation

Journal: Current Medicinal Chemistry
Volume: 11
Page: 2767-2784
Author(s): A J. Smit and H. L. Lutgers

Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4

Journal: Current Drug Metabolism
Volume: 5
Page: 415-442
Author(s): Shufeng Zhou, Eli Chan, Lee Yong Lim, Urs A. Boelsterli, Shu Chuen Li, Jiancheng Wang, Qiang Zhang, Min Huang and Anlong Xu

Non-Lipid Effects of Statins: Emerging New Indications

Journal: Current Vascular Pharmacology
Volume: 2
Page: 309-318
Author(s): Aylin Yildirir and Haldun Muderrisoglu

Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3
Page: 357-377
Author(s): Keith J. Miller, Brian J. Murphy and Mary Ann Pelleymounter